Immunohistochemical demonstration of Human papilloma virus (HPV) antigens in oral squamous cell lesions

Syrjänen, Kari; Pyrhönen, Seppo; Syrjänen, Stina; Lamberg, Matti A.

doi:10.1016/0007-117x(83)90060-4

Cited by 106 publications

(70 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In humans, HPV-associated HNSCC is strongly associated with the oropharyngeal sites, particularly the base of the tongue and the tonsil (11,41,43) in addition to other sites in the head and neck (44)(45)(46), including the esophagus (47). In the case of esophageal carcinoma, increasing reports of detection of HPV DNA and serological evidence of virus infection in these cancers are putting forth the notion that HPVs are a risk factor for this cancer, at least in those geographical regions in which there is a high incidence of this malignancy.…”

Section: K14e6͞k14e7-transgenic Mice Are More Susceptible To 4nqo-indmentioning

confidence: 99%

Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model

Strati

Pitot

Lambert

2006

Proc. Natl. Acad. Sci. U.S.A.

131

156

View full text Add to dashboard Cite

Head and neck squamous cell carcinoma (HNSCC) is a leading cause of cancer mortality worldwide. Recent reports have associated a subset of HNSCC with high-risk human papillomaviruses (HPVs), particularly HPV16, the same subset of HPVs responsible for the majority of cervical and anogenital cancers. In this study we describe a mouse model for HPV-associated HNSCC that employs mice transgenic for the HPV16 oncogenes E6 and E7. In these mice, E6 and E7 induce aberrant epithelial proliferation and, in the presence of a chemical carcinogen, they increase dramatically the animal's susceptibility to HNSCC. The cancers arising in the HPV16-transgenic mice mirror the molecular and histopathological characteristics of human HPV-positive HNSCC that distinguish the latter from human HPV-negative HNSCC, including overexpression of p16 protein and formation of more basaloid cancers. This validated model of HPV-associated HNSCC provides the means to define the contributions of individual HPV oncogenes to HNSCC and to understand the molecular basis for the differing clinical properties of HPV-positive and HPV-negative human HNSCC. From this study, we identify minichromosome maintenance protein 7 (MCM7) and p16 as potentially useful biomarkers for HPV-positive head and neck cancer.head and neck squamous cell carcinoma (HNSCC) ͉ human papillomavirus 16 (HPV16) ͉ minichromosome maintenance protein 7 (MCM7) ͉ p16 ͉ transgenic H ead and neck cancers are the sixth most common malignancy in the world (1), and recent advances in treating them are not reflected in improved survival. Head and neck squamous cell carcinoma (HNSCC) is etiologically associated with tobacco use; alcohol consumption; and, in Southeast Asia, chewing of betel nut (2-6). However, more recent studies have implicated high-risk human papillomaviruses (HR-HPVs), the same viruses recognized as the causative agents of cervical and most other anogenital malignancies, in the etiology of a subset of HNSCC (7).HR-HPV DNA has been detected in Ϸ20% of HNSCC, particularly in malignancies of the oropharynx, where Ϸ50% of the cancers have been found to harbor viral DNA. HPV16, the type associated with the majority of cervical carcinomas, is the HR-HPV linked with the overwhelming majority of HPVpositive HNSCC (95%) (8-10). Other HR-HPV genotypes have been detected, including HPV18, HPV31, and HPV33. Viral oncogenes E6 and E7, the papillomaviral genes considered largely responsible for the onset as well as persistence of cervical cancer, have been detected in both integrated and extrachromosomal HPV genomes in HNSCC (11). E6 and E7 are best known for their ability to bind and inactivate the tumor suppressors p53 and pRb (12)(13)(14)(15)(16)(17), and these respective properties have been associated with their oncogenic properties (18,19). Consistent with E6 and E7 contributing to HPV-positive HNSCC is the absence of genetic or epigenetic alterations in the p53 and pRb pathways in HPV-positive HNSCC, in stark contrast to what is observed in HPV-negative HNSCC (11). Furthermore, di...

show abstract

Section: K14e6͞k14e7-transgenic Mice Are More Susceptible To 4nqo-indmentioning

confidence: 99%

Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model

Strati

Pitot

Lambert

2006

Proc. Natl. Acad. Sci. U.S.A.

131

156

View full text Add to dashboard Cite

show abstract

“…The development of benign epithelial tumors and hyperplasia of the human oral cavity is also linked to HPV infection (zur Hausen, 1977;Summers and Booth, 1979;Shaer et al, 1980;Syrjanen et al, 1983Syrjanen et al, , 1986Syrjanen et al, , 1992Yeudall, 1992;Spitz et al, 1988;Di Luca et al, 1990), where up to 40% of the cancer tissues from oral biopsies contain HPV DNA (Chang et al, 1990).…”

Section: Abstract: Hpv; Human Oral Keratinocytes; Tumor Developmentmentioning

confidence: 99%

Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes

Rey¹,

Baluda²,

Park³

1999

Oncogene

View full text Add to dashboard Cite

“…Keerti Shah, a molecular microbiologist at the Johns Hopkins Bloomberg School of Public Health, had mentioned research in Finland that had identified HPV in a cell line developed from an oropharyngeal tumour 3 . As Shah and Gillison walked around campus one day, they talked about the finding.…”

Section: New Threatmentioning

confidence: 99%

HPV: Sex, cancer and a virus

Scudellari¹

2013

Nature

View full text Add to dashboard Cite

Immunohistochemical demonstration of Human papilloma virus (HPV) antigens in oral squamous cell lesions

Cited by 106 publications

References 16 publications

Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model

Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model

Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes

HPV: Sex, cancer and a virus

Contact Info

Product

Resources

About